Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2092]

Minimised BEACOPP exposure and toxicity for Hodgkin lymphoma gives good results

Dr Olivier Casasnovas - CHU de Dijon, Dijon, France

Minimised BEACOPP exposure and toxicity for Hodgkin lymphoma gives good results ( Dr Olivier Casasnovas - CHU de Dijon, Dijon, France )

Results from the phase I ICONIC trial

Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA

Results from the phase I ICONIC trial ( Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA )

Phase II results of olaparib and abiraterone for mCRPC

Prof Noel Clarke - Salford Royal NHS Foundation Trust, Salford, UK

Phase II results of olaparib and abiraterone for mCRPC ( Prof Noel Clarke - Salford Royal NHS Foundation Trust, Salford, UK )

Design and interim safety analysis of GeparX trial

Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany

Design and interim safety analysis of GeparX trial ( Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany )

Novel fusion proteins to target PD-L1 in HPV associated cancers

Dr James Gulley - Center for Cancer Research, Washington, USA

Novel fusion proteins to target PD-L1 in HPV associated cancers ( Dr James Gulley - Center for Cancer Research, Washington, USA )

ASCO 2018: Novel treatment strategies in prostate cancer therapeutics

Prof Karim Fizazi and Dr Neal Shore

ASCO 2018: Novel treatment strategies in prostate cancer therapeutics ( Prof Karim Fizazi and Dr Neal Shore )

Early results from a 3rd gen EGFR-TKI in advanced NSCLC

Prof Byoung Chul Cho - Yonsei Cancer Center, Seoul, the Republic of Korea

Early results from a 3rd gen EGFR-TKI in advanced NSCLC ( Prof Byoung Chul Cho - Yonsei Cancer Center, Seoul, the Republic of Korea )

Most breast cancer patients could avoid chemo with use of genetic testing

Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA

Most breast cancer patients could avoid chemo with use of genetic testing ( Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA )

Sunitinib with or without surgery for metastatic renal cell carcinoma

Prof Arnaud Mejean - Paris Descartes University, Paris, France

Sunitinib with or without surgery for metastatic renal cell carcinoma ( Prof Arnaud Mejean - Paris Descartes University, Paris, France )

What will we expect from novel therapies for oesophageal and gastric...

Prof Ramon De Mello - University of Algarve, Faro, Portugal

What will we expect from novel therapies for oesophageal and gastric malignancies? ( Prof Ramon De Mello - University of Algarve, Faro, Portugal )

Nelarabine in newly diagnosed paediatric T-cell malignancies

Dr Kimberly Dunsmore - University of Virginia School of Medicine, Virginia, USA

Nelarabine in newly diagnosed paediatric T-cell malignancies ( Dr Kimberly Dunsmore - University of Virginia School of Medicine, Virginia, USA )

First-in-human phase 1 study of TAK-931 for solid tumours

Dr Toshio Shimizu - National Cancer Center Hospital (NCCH), Tokyo, Japan

First-in-human phase 1 study of TAK-931 for solid tumours ( Dr Toshio Shimizu - National Cancer Center Hospital (NCCH), Tokyo, Japan )

More from ecancer